Jochen Roessler
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome (NCT02569125) | Jochen Roessler | 2016-01-01 |
Track Jochen Roessler automatically
Every clearance here is in the API, with alerts when new ones post.